Cytori Therapeutics (Nasdaq: CYTX) disclosed the following on Friday ... Inc. (the "Company") received a deficiency letter from the staff (the "Staff") of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it no longer meets …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX Keywords: Cytori Therapeutics, …
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX), a late stage cell therapy company developing ... M.D., Senior Vice President of Clinical Affairs, a non-qualified stock option to purchase an aggregate of …
BOSTON (MarketWatch) — GTX Inc. was the mover of note among the ... drug for the prevention of bone fractures in prostate-cancer patients. Cytori Therapeutics CYTX, +29.55% shares jumped 12%. Cytori announced positive results …
If you want a Stock Review on CBAY, CYTX, CYTR, or SRNE then come over to http://dailystocktracker.com/register/ …
Cytori Therapeutics, Inc. (NASDAQ: CYTX) entered into a definitive securities purchase ... with each unit consisting of one share of its Series A 3.6% convertible preferred stock, which shall be convertible into the Company's common stock
Cytori Therapeutics Inc. (NASDAQ: CYTX), Endo Health Solutions Inc. (NASDAQ ... This is now about 5-times normal trading volume and the stock hit a yearly high of $14.07 earlier in the day. This move took the market cap up to over …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX Keywords: Cytori Therapeutics, …